Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC
by on Monday, July 16th, 2012 | No Comments
Condition: Hepatic Neoplasm Malignant Recurrent
Interventions: Drug: NIK-333(peretinoin); Drug: Placebo
Sponsors: Kowa Company, Ltd.; Kowa Company, Ltd.
Recruiting – verified July 2012
Read the original: Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC